Suppr超能文献

保加利亚阵发性夜间血红蛋白尿的流行病学估计。

Epidemiological estimates of paroxysmal nocturnal hemoglobinuria in Bulgaria.

作者信息

Beleva Elina

机构信息

Clinic of Hematology, Military Medical Academy, Sofia, Bulgaria.

QSAR and Molecular modelling, Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria.

出版信息

Intractable Rare Dis Res. 2024 Aug 31;13(3):190-194. doi: 10.5582/irdr.2024.01016.

Abstract

Paroxysmal nocturnal hemoglobinuria is a rare clonal hematopoietic stem cell disorder with debilitating health consequences if untreated. Although cases have been described globally, precise epidemiological distribution is difficult to assess due to geographical underrepresentation in disease reporting. Evaluation of the burden of paroxysmal nocturnal hemoglobinuria in Bulgaria is currently missing. To provide epidemiological estimates, a systematic literature search for publications in the Bulgarian language or by Bulgarian authors was performed for a ten-year period (2013-2022), and clinically relevant information on case presentation was collected. Additionally, data was retrieved from the National Health Insurance Fund and National Statistical Institute on the count of registered cases with ICD-10 code "D59.5" and census for the same period. The estimated prevalence of paroxysmal nocturnal hemoglobinuria is relatively lower in the Bulgarian population than in other countries, and it is estimated to be 2.77 cases per 1,000,000 patient years. The treatment pattern mainly shows conventional blood product support use and is consistent with the pre-complement inhibition era. Underdiagnosis, lack of a reliable disease reporting system, and, until recently, restricted access to complement inhibitor therapy are significant impediments to the management of paroxysmal nocturnal hemoglobinuria in Bulgaria.

摘要

阵发性睡眠性血红蛋白尿是一种罕见的克隆性造血干细胞疾病,若不治疗会对健康造成严重影响。尽管全球均有病例报道,但由于疾病报告中存在地理代表性不足的情况,精确的流行病学分布难以评估。目前尚缺乏对保加利亚阵发性睡眠性血红蛋白尿负担的评估。为提供流行病学估计数,我们对十年期间(2013 - 2022年)以保加利亚语发表或由保加利亚作者撰写的出版物进行了系统的文献搜索,并收集了有关病例表现的临床相关信息。此外,还从国家健康保险基金和国家统计局检索了国际疾病分类第十版(ICD - 10)代码为“D59.5”的登记病例数以及同期人口普查数据。保加利亚人群中阵发性睡眠性血红蛋白尿的估计患病率相对低于其他国家,估计为每100万患者年2.77例。治疗模式主要表现为使用传统血液制品支持,这与补体抑制时代之前一致。诊断不足、缺乏可靠的疾病报告系统以及直到最近补体抑制剂治疗的可及性受限,都是保加利亚阵发性睡眠性血红蛋白尿管理的重大障碍。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验